%0 Journal Article
%T Cost-Effectiveness Analysis of Renalof<sup>&#174;</sup> versus Extracorporeal Shockwave Lithotripsy (ESWL) for the Treatment of Kidney Stones &#8804; 1 cm in Nicaragua
%A M¨¦lida M. Aguilar Chamorro
%A Sergio Vargas Collado
%A Leslie P¨¦rez Ru¨ªz
%A David M¨¢rquez Soriano
%A Jorge Luis Soriano Garc¨ªa
%J Health
%P 674-687
%@ 1949-5005
%D 2024
%I Scientific Research Publishing
%R 10.4236/health.2024.167047
%X <b>Objectives</b>: To assess the efficiency in terms of cost-effectiveness (CE) of oral Renalof<sup>&#174;</sup> treatment versus extracorporeal shockwave lithotripsy (ESWL) in the treatment of kidney stones &#8804; 1 cm in Nicaragua. <b>Methods</b>: A cost-effectiveness economic evaluation was carried out based on the results obtained in the randomised, prospective, observational, single-blind, prospective, phase 2 clinical trial. Cost-effectiveness and the incremental cost-effectiveness ratio (ICER) were calculated. Economic data were obtained from the Economics Department of Cl&#237;nica Senior in Managua, Nicaragua. The monetary cost was expressed in US dollars (USD). <b>Results</b>: Treatment with Renalof<sup>&#174;</sup> yielded a CE of $1,323.08/% remission, while ESWL was $9,498.54/% remission. The ICER shows that, in order to achieve a high percentage of kidney stone remission with ESWL, an extra $4,734.70 per patient must be invested. <b>Conclusions</b>: The use of Renalof<sup>&#174;</sup> is shown to be a more cost-effective option than ESWL. It is recommended for the treatment of kidney stones &#8804; 1 cm in size.
%K Economic Evaluation
%K Pharmacoeconomics
%K Renalof<sup>&#174
%K </sup>
%K Extracorporeal Shockwave Lithotripsy
%K Kidney Stones
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=134804